The Schroder Institutional UK Equity Fund (No.2)'s principal investment objective is to seek to achieve capital growth through investment in UK equities either directly,or in the case of certain specialised areas such as smaller companies,via other collective investment schemes.
Name | % Net Assets |
---|---|
Royal Dutch Shell Plc 'B' | 6.8% |
BG Group Plc | 6.3% |
GlaxoSmithKline Plc | 5.9% |
Vodafone Group Plc | 4.8% |
Anglo American Plc | 4.8% |
Unilever Plc | 4.8% |
BP Plc | 4.2% |
Centrica Plc | 3.6% |
HSBC Holdings | 3.3% |
AstraZeneca Plc | 2.6% |
Key | % Net Assets |
---|---|
Royal Dutch Shell Plc 'B' | 6.8% |
BG Group Plc | 6.3% |
GlaxoSmithKline Plc | 5.9% |
Vodafone Group Plc | 4.8% |
Other | 76.2% |
Date | n/a |
---|---|
Bid | 0.00 |
Offer | 0.00 |
Currency | n/a |
Change | 0.00 |
% | n/a |
YTD change | 0.00 |
YTD % | n/a |
Fund Inception | 01/11/1999 |
---|---|
Fund Manager | Jeremy Smith |
TER | - |
Minimum Investment | |
---|---|
Initial | 500000 |
Additional | n/a |
Savings | n/a |
Charges | |
---|---|
Initial | 3.00% |
Annual Mang't | 0.50% |
Exit | n/a |
Name | % |
---|---|
Standard deviation | 0.01 |
Sharpe ratio | 0.08 |
You are here: research